Anmeldung erfolgt in Kürze...
Details werden geladen...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on August 3, 2026 (the 'Grant Date”), ORIC granted a total of 125,400 non-qualified stock options and 20,550 restricted stock units to five new non-executive employees who began their employment with ORIC in July 2026.
Ähnliche Seiten
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2359870
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/03/tmt-newswire/globenewswire/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2377821Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357297Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/08/01/tmt-newswire/globenewswire/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2396166Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/30/tmt-newswire/globenewswire/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2354842